Wednesday, October 04, 2023 10:20:24 AM
Here is the link , but I pasted highlights below.
https://www.otcmarkets.com/stock/MEDIF/news/MediPharm-Labs-Settles-an-Outstanding-Claim-for-9M?id=415985
Settlement Highlights
Upon the acquisition of HEXO Corp. by Tilray Brands (NASDAQ: TLRY), MediPharm and Tilray sought a resolution that was favorable to each party and established a long-term supply relationship in connection with the settlement agreement. Under the agreement, MediPharm will receive a total value consideration of $9 million including:
$3 million immediate cash payment;
$4.5 million in common shares of Tilray;
$1 million in Tilray cannabis products, including high-quality flower and extractable bio-mass; and
$500,000 supply agreement to provide Tilray with MediPharm products and services over four years.
This long-term supply agreement will allow MediPharm to establish a positive ongoing business relationship with a global leader in the cannabis industry. The deal is also expected to benefit Tilray through access to MediPharm's unique pharmaceutical products and services both domestically and internationally, including products produced under the company's US FDA Foreign Drug Site registration and Canadian Pharmaceutical Drug Establishment License.
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM